0001437749-14-021726.txt : 20141205
0001437749-14-021726.hdr.sgml : 20141205
20141205171434
ACCESSION NUMBER: 0001437749-14-021726
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141204
FILED AS OF DATE: 20141205
DATE AS OF CHANGE: 20141205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TearLab Corp
CENTRAL INDEX KEY: 0001299139
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 593434771
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9980 HUENNEKENS ST.
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-794-1400
MAIL ADDRESS:
STREET 1: 9980 HUENNEKENS ST.
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: OccuLogix, Inc.
DATE OF NAME CHANGE: 20040730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VAMVAKAS ELIAS
CENTRAL INDEX KEY: 0001061865
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51030
FILM NUMBER: 141270334
MAIL ADDRESS:
STREET 1: 5280 SOLAR DRIVE
STREET 2: SUITE 100
CITY: MISSISSAUGA
STATE: A6
ZIP: L4W 5M8
4
1
rdgdoc.xml
FORM 4
X0306
4
2014-12-04
0001299139
TearLab Corp
TEAR
0001061865
VAMVAKAS ELIAS
9980 HUENNEKENS ST., STE 100
SAN DIEGO
CA
92121
1
1
Chairman and CEO
Common Stock
2014-12-04
4
P
0
50000
2.2428
A
320000
I
See footnote
Common Stock
1308139
I
See footnote
Common Stock
201404
D
Represents the weighted average share price of an aggregate total of 50,000 shares purchased in the price range of $2.18 to $2.25 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Shares held by Greybrook Corporation. The reporting person is an officer and a director of Greybrook Corporation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Shares held by Greybrook Capital, Inc. The reporting person is an officer and a director of Greybrook Capital Inc. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
/s/ William Dumencu, as Attorney-in-Fact
2014-12-05